Using Biomarkers to Predict TB Treatment Duration
Clinical trial NCT02821832 · COMPLETED
Trial details
- NCT number
- NCT02821832
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-21
- Primary completion
- 2021-10-09
- Enrollment
- 946
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.